It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Epithelial cells provide cell-cell adhesion that is essential to maintain the integrity of multicellular organisms. Epithelial cell-characterizing proteins, such as epithelial junctional proteins and transcription factors are well defined. However, the role of lipids in epithelial characterization remains poorly understood. Here we show that the phospholipid phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] is enriched in the plasma membrane (PM) of epithelial cells. Epithelial cells lose their characteristics upon depletion of PM PI(4,5)P2, and synthesis of PI(4,5)P2 in the PM results in the development of epithelial-like morphology in osteosarcoma cells. PM localization of PARD3 is impaired by depletion of PM PI(4,5)P2 in epithelial cells, whereas expression of the PM-targeting exocyst-docking region of PARD3 induces osteosarcoma cells to show epithelial-like morphological changes, suggesting that PI(4,5)P2 regulates epithelial characteristics by recruiting PARD3 to the PM. These results indicate that a high level of PM PI(4,5)P2 plays a crucial role in the maintenance of epithelial characteristics.
Epithelial cells provide cell-cell adhesion to maintain the integrity of multicellular organisms. Here the authors show that phospholipid phosphatidylinositol (4,5)-bisphosphate is critical for the maintenance of epithelial characteristics.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Tokyo University of Science, Department of Applied Biological Science, Faculty of Science and Technology, Noda, Japan (GRID:grid.143643.7) (ISNI:0000 0001 0660 6861)
2 Tokyo University of Pharmacy and Life Sciences, Laboratory of Genome and Biosignals, School of Life Sciences, Hachioji, Japan (GRID:grid.410785.f) (ISNI:0000 0001 0659 6325)
3 Tokyo Medical and Dental University, Department of Biochemical Pathophysiology, Medical Research Institute, Bunkyo-ku, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130); Tokyo Medical and Dental University, Department of Lipid Biology, Graduate School of Medical and Dental Sciences, Bunkyo-ku, Japan (GRID:grid.265073.5) (ISNI:0000 0001 1014 9130)
4 Akita University, Research Center for Biosignal, Akita-city, Japan (GRID:grid.251924.9) (ISNI:0000 0001 0725 8504); Lipidome Lab Co., Ltd, Akita-city, Japan (GRID:grid.251924.9)
5 Hokkaido University Graduate School of Life Science, Division of Molecular Interaction, Institute for Genetic Medicine, Sapporo, Japan (GRID:grid.39158.36) (ISNI:0000 0001 2173 7691)
6 Kobe University, Biosignal Research Center, Kobe, Japan (GRID:grid.31432.37) (ISNI:0000 0001 1092 3077); Kobe University Graduate School of Medicine, Division of Membrane Biology, Department of Biochemistry and Molecular Biology, Kobe, Japan (GRID:grid.31432.37) (ISNI:0000 0001 1092 3077)